Lars Tögel

1.2k citations
26 papers · 629 indexed · h-index 13

Lars Tögel

23 papers receiving 619 citations

Peers

Lars Tögel
Comparison fields: 5 of 83
  • Molecular Biology 381
  • Oncology 142
  • Cancer Research 74
  • Immunology 79
  • Hematology 37
Replace Claudia Gemelli with:
Claudia Gemelli Italy
Guoping Huang China
Sumihito Togi Japan
Liliana Terrin Italy
Chung-Ping Liao United States
Yulan Qing United States
Shen‐Wu Wang China
Yoko Takahashi Japan
Xiwen Dong China
Lixin Fu China
Lars Tögel relative to Claudia Gemelli Italy Claudia Gemelli's profile →
Citations per field
00.5×2.9×
Claudia Gemelli · 1×
Citations per year

Countries citing papers authored by Lars Tögel

Since Specialization
Citations

This map shows the geographic impact of Lars Tögel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Tögel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Tögel more than expected).

Fields of papers citing papers by Lars Tögel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Tögel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Tögel. The network helps show where Lars Tögel may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lars Tögel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lars Tögel Line = papers co-authored together Lars Tögel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20250
4 20245
5 20243
6 202313
7 20233
8 202015
9 202019
10 202040
11 20202
12 201812
13 201744
14 201674
15 201462
16 201448
17 201352
18 201226
19 201096
20 200961

About Lars Tögel

Lars Tögel is a scholar working on Dermatology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism, having authored 26 papers that have together received 629 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (6 papers), Protein Degradation and Inhibitors (5 papers), Cancer Genomics and Diagnostics (4 papers), Cancer and Skin Lesions (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Salivary Gland Tumors Diagnosis and Treatment (3 papers), Vascular Tumors and Angiosarcomas (2 papers) and Soft tissue tumor case studies (2 papers). The work is most often cited by research in Molecular Biology (381 citations), Oncology (142 citations), Cancer Research (74 citations), Immunology (79 citations) and Hematology (37 citations). Lars Tögel has collaborated with scholars based in Germany, United States and Australia. Frequent co-authors include John M. Mariadason, Anderly C. Chüeh, Janson W.T. Tse, Diego Arango, Abbas Agaimy, Florian Haller, Amardeep S. Dhillon, Georgia Corner, Leonard H. Augenlicht and Robert Stoehr. Their work appears in journals such as Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, The American Journal of Surgical Pathology, Cancers, Journal of Biological Chemistry and Head and Neck Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026